Meadow Creek Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Meadow Creek Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$9.06M	Buy	70,728 +8,316	+13%	+$1.11M	0.18%	102
2019 Q2	$8.9M	Buy	62,412 +3,864	+7%	+$519K	0.18%	114
2019 Q1	$8.37M	Buy	58,548 +23,856	+69%	+$3.11M	0.17%	121
2018 Q4	$4.3M	Buy	34,692 +32,900	+1,836%	+$4.88M	0.1%	195
2018 Q3	$301K	Buy	1,792 +1,568	+700%	+$270K	0.01%	925
2018 Q2	$39K	Buy	+224	New	+$36.6K	﹤0.01%	1272

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meadow Creek Investment Management's JAZZ Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q3 2019, buying an estimated $1.11M and bringing the position to 70,728 shares worth $9.06M. The position accounts for 0.18% of the portfolio, ranked #102.

Meadow Creek Investment Management first reported a position in JAZZ in Q2 2018 and has held it in 6 quarters since. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

Meadow Creek Investment Management held 70,728 shares of Jazz Pharmaceuticals worth $9.06M as of Q3 2019.
Meadow Creek Investment Management bought 8,316 Jazz Pharmaceuticals shares in Q3 2019, an estimated $1.11M.
Jazz Pharmaceuticals made up 0.18% of Meadow Creek Investment Management's portfolio in Q3 2019, its #102 holding.
Meadow Creek Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 6 quarters since.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.